EP1048641A4 - Inducteurs de l'apoptose - Google Patents

Inducteurs de l'apoptose

Info

Publication number
EP1048641A4
EP1048641A4 EP98957228A EP98957228A EP1048641A4 EP 1048641 A4 EP1048641 A4 EP 1048641A4 EP 98957228 A EP98957228 A EP 98957228A EP 98957228 A EP98957228 A EP 98957228A EP 1048641 A4 EP1048641 A4 EP 1048641A4
Authority
EP
European Patent Office
Prior art keywords
apoptosis inducer
apoptosis
carcinostatic
viii
vii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98957228A
Other languages
German (de)
English (en)
Other versions
EP1048641A1 (fr
Inventor
Tatsuji Enoki
Nobuto Koyama
Katsushige Ikai
Ikunoshin Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takara Bio Inc
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Publication of EP1048641A1 publication Critical patent/EP1048641A1/fr
Publication of EP1048641A4 publication Critical patent/EP1048641A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/60—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385—Saturated compounds containing a keto group being part of a ring
    • C07C49/487—Saturated compounds containing a keto group being part of a ring containing hydroxy groups
    • C07C49/493—Saturated compounds containing a keto group being part of a ring containing hydroxy groups a keto group being part of a three- to five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/707—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a three- to five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

L'invention porte sur des inducteurs de l'apoptose représentés par les formules chimiques (I), (II), (VIII), (IV), (V), (VI), (III) and (VII) et sur des préparations médicinales les contenant et pouvant servir de carcinostatiques et analogues.
EP98957228A 1997-12-11 1998-12-08 Inducteurs de l'apoptose Withdrawn EP1048641A4 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
JP36164497 1997-12-11
JP36164497 1997-12-11
JP36435697 1997-12-19
JP36435697 1997-12-19
JP36481397 1997-12-22
JP36481397 1997-12-22
JP1766098 1998-01-14
JP1766098 1998-01-14
JP7301898 1998-03-09
JP7301898 1998-03-09
PCT/JP1998/005554 WO1999029647A1 (fr) 1997-12-11 1998-12-08 Inducteurs de l'apoptose

Publications (2)

Publication Number Publication Date
EP1048641A1 EP1048641A1 (fr) 2000-11-02
EP1048641A4 true EP1048641A4 (fr) 2004-11-24

Family

ID=27519944

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98957228A Withdrawn EP1048641A4 (fr) 1997-12-11 1998-12-08 Inducteurs de l'apoptose

Country Status (6)

Country Link
US (2) US6525082B1 (fr)
EP (1) EP1048641A4 (fr)
KR (1) KR20010015872A (fr)
CN (1) CN1125023C (fr)
CA (1) CA2313517A1 (fr)
WO (1) WO1999029647A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720415B2 (en) 1998-12-02 2004-04-13 Princeton University Compositions and methods for regulating bacterial pathogenesis
US7326542B2 (en) 1998-12-02 2008-02-05 Princeton University Compositions and methods for regulating bacterial pathogenesis
AU3665700A (en) * 1999-03-22 2000-10-09 Charterhouse Therapeutics Ltd. Chemical compounds and their uses
US6559176B1 (en) 2000-05-10 2003-05-06 Princeton University Compounds and methods for regulating bacterial growth and pathogenesis
US20080274955A1 (en) * 2004-04-13 2008-11-06 Kyungpook National University Industry Academic Cooperation Foundation Novel Use of a Polypeptide Comprising Fas-1 Domain

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311055A (en) * 1970-12-08 1973-03-21 Givaudan & Cie Sa Aromatizing agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3381691A (en) 1965-11-08 1968-05-07 Reynolds Tobacco Co R Tobacco product
JPS56102851A (en) 1980-01-21 1981-08-17 Konishiroku Photo Ind Co Ltd Photosensitive element
FR2678263B1 (fr) 1991-06-26 1995-03-03 Oreal Meta-aminophenols, leur utilisation en tant que coupleurs pour la teinture d'oxydation des fibres keratiniques, compositions et procede de teinture.
WO1998039291A1 (fr) 1997-03-05 1998-09-11 Takara Shuzo Co., Ltd. Composes
ATE228110T1 (de) 1997-03-11 2002-12-15 Takara Shuzo Co Cyclopentenon-derivate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311055A (en) * 1970-12-08 1973-03-21 Givaudan & Cie Sa Aromatizing agent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OSKAR AXELSSON ET AL.: "BASE-CATALYSED SELF-CONDENSATION OF ARYLACETALDEHYDES:", AUST. J. CHEM., vol. 41, no. 5, 1988, AUSTRALIA, pages 727 - 33, XP008035814 *
See also references of WO9929647A1 *

Also Published As

Publication number Publication date
KR20010015872A (ko) 2001-02-26
US20030065014A1 (en) 2003-04-03
CA2313517A1 (fr) 1999-06-17
US6803367B2 (en) 2004-10-12
WO1999029647A1 (fr) 1999-06-17
CN1125023C (zh) 2003-10-22
US6525082B1 (en) 2003-02-25
EP1048641A1 (fr) 2000-11-02
CN1281426A (zh) 2001-01-24

Similar Documents

Publication Publication Date Title
ZA9711313B (en) Stilbene compounds containing an adamantyl-group, compositions containing them and uses thereof.
CA2276455A1 (fr) Phthalazinones
EP0617092A3 (fr) Revêtement diffusant la lumière, préparation et usage.
CA2109259A1 (fr) Precurseurs de medicaments, leur preparation et leur utilisation en pharmaceutique
AU3827097A (en) Naphthopyrans, compositions and articles containing them
ID23374A (id) Halogenopirimidin
AU5130299A (en) Wrist-mounted i.v. administration set
DE69905170D1 (en) Thiazolopyrimidinderivate
ZA964711B (en) Novel compounds, the preparation and use thereof.
AU3813499A (en) The use of dihydropyrimidines as medicaments, and novel substances
TR200000152T2 (tr) Yeni bileşikler.
EP0247167A4 (fr) Composes d'hydroxy et d'aminothiazolyl-benzodiazinone, compositions cardiotoniques les contenant et leurs emplois.
HK1030218A1 (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same.
AP9400655A0 (en) New pesticides
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
AU1725188A (en) Pyridooxazinone-pyridone compounds, cardiotonic compositions including the same, and their uses
YU5800A (sh) Univerzalno primenljiva krvna plazma
HK1032785A1 (en) Novel 3,6-hemiketals from the class of 9a-azalides
ES2193539T3 (es) Benzonaftiridinas.
AU4844496A (en) Novel biphenyl derivatives or salts thereof, and anti-inflammatory agents containing the same
EP0638080A4 (fr) PYRIMIDINE 7-BISUBSTITUEE-METHYL-4-OXO-3H -, 5H --PYRROLO 3,2-d -], UTILISATION PHARMACEUTIQUE ET COMPOSITIONS CONTENANT LADITE PYRIMIDINE.
EP0247177A4 (fr) Composes de benzodiazinone-pyridazinone et d'hydroxy-pyrazolyl, compositions cardiotoniques les contenant, et leurs emplois.
EP1048641A4 (fr) Inducteurs de l'apoptose
GB2324091A (en) Metalloproteinase inhibitors
ZA979643B (en) Heterocyclic compounds, compositions and uses.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000706

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TAKARA BIO INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 35/00 B

Ipc: 7C 07C 45/60 B

Ipc: 7C 07D 521/00 B

Ipc: 7A 61K 31/44 B

Ipc: 7A 61K 31/415 B

Ipc: 7A 61K 31/165 B

Ipc: 7A 61K 31/12 B

Ipc: 7C 07D 513/18 B

Ipc: 7C 07D 233/60 B

Ipc: 7C 07D 213/65 B

Ipc: 7C 07C 233/25 B

Ipc: 7C 07C 229/08 B

Ipc: 7C 07C 49/753 B

Ipc: 7C 07C 49/707 A

A4 Supplementary search report drawn up and despatched

Effective date: 20041007

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060314